Tetsuya Hirabayashi

Dr. Tetsuya Hirabayashi

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2011 in Progress in Lipid Research
Verified
Journal Article
Closed access
MMMakoto Murakami
Makoto Murakami
YTYoshitaka Taketomi
Yoshitaka Taketomi
YMYoshimi Miki
Yoshimi Miki
HSHiroyasu Sato
Hiroyasu Sato
THTetsuya Hirabayashi
Tetsuya Hirabayashi
KYKei Yamamoto
Kei Yamamoto

1 January 2004 in Biological and Pharmaceutical Bulletin
Verified
Journal Article
Closed access
PDF file
THTetsuya Hirabayashi
Tetsuya Hirabayashi
TMToshihiko Murayama
Toshihiko Murayama
TSTakao Shimizu
Takao Shimizu
Cytosolic phospholipase A2α (cPLA2α) preferentially hydrolyzes phospholipids containing arachidonic acid and plays a key role in the biosynthesis of eicosanoids. This review discusses the essential features of cPLA2α regulation and addresses new insights into the functional properties of this enzyme. Full activation of the enzyme requires Ca2+ binding to an N-terminal C2 domain and phosphorylation on serine residues. Ca2+ binding induces translocation of cPLA2α from the cytosol to the perinuclear membranes. Serine phosphorylation is mediated by mitogen-activated protein kinases (MAPKs), Ca2+/calmodulin-dependent protein kinase II, and MAPK-interacting kinase Mnk1. Interaction with proteins and lipids, which include vimentin, annexins, NADPH oxidase, phosphatidylcholine, phosphatidylinositol 4,5-bisphosphate (PIP2), and ceramide-1-phosphate, can also modulate the activity of cPLA2α. Recent evidence has established the physiological and pathological roles of cPLA2α using cPLA2α knockout mice. This enzyme has been implicated in fertility, striated muscle growth, renal concentration, postischemic brain injury, arthritis, inflammatory bone resorption, intestinal polyposis, pulmonary fibrosis, acute respiratory distress syndrome, and autoimmune encephalomyelitis. Now novel three paralogs, cPLA2β, cPLA2γ, and cPLA2δ, have been identified in humans. cPLA2γ is distinct from others in that it is farnesylated and lacks the C2 domain. Biological roles for these new enzymes have not yet been defined.

1 October 2000 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
THTetsuya Hirabayashi
Tetsuya Hirabayashi
TSTakao Shimizu
Takao Shimizu

1 February 1999 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
THTetsuya Hirabayashi
Tetsuya Hirabayashi
KKKazuhiko Kume
Kazuhiko Kume
KHKenzo Hirose
Kenzo Hirose
TYTakehiko Yokomizo
Takehiko Yokomizo
MIMasamitsu Iino
Masamitsu Iino
TSTakao Shimizu
Takao Shimizu
When cells are exposed to certain external stimuli, arachidonic acid (AA) is released from the membrane and serves as a precursor of various types of eicosanoids. A Ca2+-regulated cytosolic phospholipase A2(cPLA2) plays a dominant role in the release of AA. To closely examine the relation between Ca2+ response and AA release by stimulation of G protein-coupled receptors, we established several lines of Chinese hamster ovary cells expressing platelet-activating factor receptor or leukotriene B4receptor. Measurement of intracellular Ca2+ concentration ([Ca2+]i) demonstrated that cell lines capable of releasing AA elicited a sustained [Ca2+]iincrease when stimulated by agonists. The prolonged [Ca2+]i elevation is the result of Ca2+ entry, because this elevation was blocked by EGTA treatment or in the presence of Ca2+ channel blockers (SKF 96365 and methoxyverapamil). cPLA2 fused with a green fluorescent protein (cPLA2-GFP) translocated from the cytosol to the perinuclear region in response to increases in [Ca2+]i. When EGTA was added shortly after [Ca2+]i increase, the cPLA2-GFP returned to the cytosol, without liberating AA. After a prolonged [Ca2+]i increase, even by EGTA treatment, the enzyme was not readily redistributed to the cytosol. Thus, we propose that a critical time length of [Ca2+]i elevation is required for continuous membrane localization and full activation of cPLA2.

1 July 2014 in Cell Metabolism
Verified
Journal Article
Closed access
HSHiroyasu Sato
Hiroyasu Sato
YTYoshitaka Taketomi
Yoshitaka Taketomi
AUAyako Ushida
Ayako Ushida
YIYuki Isogai
Yuki Isogai
TKTakumi Kojima
Takumi Kojima
MMMakoto Murakami
Makoto Murakami

1 March 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
THTetsuya Hirabayashi
Tetsuya Hirabayashi
TATatsuki Anjo
Tatsuki Anjo
AKArisa Kaneko
Arisa Kaneko
YSYuuya Senoo
Yuuya Senoo
ASAkitaka Shibata
Akitaka Shibata
MMMakoto Murakami
Makoto Murakami
Mutations in patatin-like phospholipase domain-containing 1 (PNPLA1) cause autosomal recessive congenital ichthyosis, but the mechanism involved remains unclear. Here we show that PNPLA1, an enzyme expressed in differentiated keratinocytes, plays a crucial role in the biosynthesis of ω-O-acylceramide, a lipid component essential for skin barrier. Global or keratinocyte-specific Pnpla1-deficient neonates die due to epidermal permeability barrier defects with severe transepidermal water loss, decreased intercellular lipid lamellae in the stratum corneum, and aberrant keratinocyte differentiation. In Pnpla1−/− epidermis, unique linoleate-containing lipids including acylceramides, acylglucosylceramides and (O-acyl)-ω-hydroxy fatty acids are almost absent with reciprocal increases in their putative precursors, indicating that PNPLA1 catalyses the ω-O-esterification with linoleic acid to form acylceramides. Moreover, acylceramide supplementation partially rescues the altered differentiation of Pnpla1−/− keratinocytes. Our findings provide valuable insight into the skin barrier formation and ichthyosis development, and may contribute to novel therapeutic strategies for treatment of epidermal barrier defects.